NCT06145308 2026-04-02Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular TypingPeking Union Medical CollegePhase 2 Recruiting39 enrolled
NCT06348264 2025-09-23Adjuvant Rezvilutamide in Combination With Androgen Deprivation Therapy in Androgen Receptor-positive, High-risk Salivary Duct CarcinomaPeking University First HospitalPhase 2 Recruiting37 enrolled